HOME >> MEDICINE >> NEWS
Blocking adhesion protein may reduce lung damage from radiation

Lung inflammation, lung damage, and diminished lung performance caused by radiation of the lungs are reduced in mice genetically engineered to lack a protein called intercellular adhesion molecule-1, or ICAM-1, researchers report in the May 15 issue of the Journal of the National Cancer Institute.

These findings suggest that drugs that block the activity of ICAM-1 could be used to prevent radiation therapy-related problems, conclude Dennis E. Hallahan, M.D., and his colleagues at Vanderbilt University in Nashville, Tenn.

Therapeutic chest irradiation often results in complications such as radiation pneumonitis (lung inflammation), pulmonary fibrosis (the accumulation of collagen, or scar tissue, in the lungs), and respiratory insufficiency (diminished lung performance). These problems limit the ability of physicians to effectively treat lung cancer using radiation.

Earlier studies suggested that acute inflammation could be prevented in radiation-treated mice that were genetically engineered to lack ICAM-1, a cell adhesion molecule that mediates the recruitment of leukocytes, or white blood cells, to the lungs. Leukocytes contribute to inflammation, which leads to fibrosis and decreased lung performance. However, it remains unclear whether blocking ICAM-1 expression can also prevent fibrosis and respiratory insufficiency.

To determine the role of ICAM-1 in pulmonary fibrosis and lung performance, Hallahan and his coworkers treated groups of 10 mice with either mock irradiation or with varying doses of radiation to the thorax. Some of the mice were genetically engineered to lack the ICAM-1 gene, while others had a normal ICAM-1 gene. The researchers measured the degree of lung inflammation, fibrosis, and decreased lung performance in the groups of mice.

Lungs of mice that lacked the ICAM-1 gene had markedly fewer infiltrating leukocytes, whose presence indicates inflammation, at all radiation doses compared with t
'"/>

Contact: Linda Wang
jncimedia@oupjournals.org
301-841-1287
Journal of the National Cancer Institute
14-May-2002


Page: 1 2

Related medicine news :

1. Blocking molecules protects health of implants
2. Blocking selected neurotransmitter activity may decrease alcohol consumption
3. Blocking immune response to spinal cord injury can improve chances for recovery
4. Blocking enzyme found to ease anxiety without causing sedation
5. Blocking pathway overcomes tumor vessel resistance to radiation
6. Blocking gene may reduce lung scarring caused by radiation therapy
7. Antibody solution may prevent adhesions after surgery
8. Targeting mutant B-Raf protein reduces melanoma development
9. Mechanism of RNA recoding: New twists in brain protein production
10. Epstein-Barr virus protein crucial to its role in blood cancers
11. Neuronal death and processing of Tau protein in Alzheimers disease

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/15/2020)... ... May 15, 2020 , ... As businesses prepare to reopen, preventative ... is a need to combat the spread of the virus in a way that ... hopes to help with their TempCheck Sentinel and TempCheckplus Sentry no-contact infrared temperature sensing ...
(Date:5/14/2020)... , ... May 14, 2020 , ... ... addressing unmet needs in the field of urology, today announced that John Pettit, ... UroLift® Center of Excellence. The designation recognizes that Dr. Pettit has achieved a ...
(Date:5/14/2020)... VEGAS (PRWEB) , ... May 14, 2020 , ... ... processing, is donating to the Nevada Community Foundation’s COVID-19 Emergency Response Fund in ... the Coronavirus (COVID-19) pandemic. , Nevada Community Foundation and Nevada COVID-19 Response, ...
(Date:5/14/2020)... ... May 13, 2020 , ... Responding to a request from the Federal ... Services (CMS), DLA awarded Federal Resources a contract to provide 1.2 million pieces of ... gloves to ensure the safety and well-being of America’s seniors during the COVID-19 pandemic. ...
(Date:5/11/2020)... ... May 11, 2020 , ... PathologyWatch announced today a ... Creek Capital with additional funding by individual investors. PathologyWatch is emerging as ... diagnostic process while reducing costs to clinics and enhancing patient care. ...
Breaking Medicine News(10 mins):
(Date:5/16/2020)... ... May 16, 2020 , ... Oakworks Medical, a leading manufacturer of ... to help patients lay face down for extended periods and possibly prevent them from ... years to PTs and Pain Management professionals. We used our expertise to design a ...
(Date:5/14/2020)... , ... May 14, 2020 , ... A new study ... family caregivers in the United States increased by 9.5 million from 2015 to 2020 ... 2020 also reveals that family caregivers are in worse health compared to five years ...
(Date:5/14/2020)... MENLO PARK, Calif. (PRWEB) , ... May 14, 2020 , ... ... platform, today announced the raise of a $18M strategic round of funding led by ... Khosla Ventures, GV, Felicis Ventures, and HBM Genomics. To date, Clear Labs has raised ...
Breaking Medicine Technology:
Cached News: